Metabolic syndrome and cardiometabolic risk in PCOS. (Q36718602)

15 August 2017

1 reference

title

Metabolic syndrome and cardiometabolic risk in PCOS. (English)

1 reference

15 August 2017

1 reference

Andrea J Cussons

1

1 reference

15 August 2017

Bronwyn G A Stuckey

series ordinal

2

1 reference

15 August 2017

Gerald F Watts

series ordinal

3

1 reference

15 August 2017

publication date

1 February 2007

1 reference

15 August 2017

published in

Current diabetes report

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

66-73

1 reference

Screening women with polycystic ovary syndrome for metabolic syndrome

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0012-8

Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0012-8

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0012-8

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0012-8

Hemostatic and metabolic variables in women with polycystic ovary syndrome

21 January 2018

1 reference

12 December 2020

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

12 December 2020

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

1 reference

12 December 2020

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study

1 reference

12 December 2020

Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin.

1 reference

12 December 2020

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study

1 reference

12 December 2020

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

1 reference

12 December 2020

Cardiopulmonary impairment in young women with polycystic ovary syndrome.

1 reference

12 December 2020

Menstrual cycle irregularity and risk for future cardiovascular disease

1 reference

12 December 2020

Altered vascular function in young women with polycystic ovary syndrome

1 reference

12 December 2020

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome

1 reference

12 December 2020

Metabolic syndrome in young Czech women with polycystic ovary syndrome.

1 reference

12 December 2020

Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome

1 reference

12 December 2020

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

1 reference

12 December 2020

Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy

1 reference

12 December 2020

Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills

1 reference

12 December 2020

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

1 reference

12 December 2020

Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.

1 reference

12 December 2020

Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes

1 reference

12 December 2020

Vascular dysfunction and metabolic parameters in polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

1 reference

12 December 2020

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

1 reference

12 December 2020

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

12 December 2020

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

12 December 2020

Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality

1 reference

12 December 2020

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

1 reference

12 December 2020

Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women

1 reference

12 December 2020

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

1 reference

12 December 2020

Polycystic ovary syndrome and cardiovascular disease: a premature association?

1 reference

12 December 2020

Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome

1 reference

12 December 2020

Adiponectin levels in women with polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance

1 reference

12 December 2020

Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Adiponectin: a key adipocytokine in metabolic syndrome

1 reference

12 December 2020

Androgens and coronary artery disease

1 reference

12 December 2020

Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease

1 reference

12 December 2020

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

1 reference

12 December 2020

Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy

1 reference

12 December 2020

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

12 December 2020

Obesity and polycystic ovary syndrome

1 reference

12 December 2020

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

1 reference

12 December 2020

How prevalent is metabolic syndrome in women with polycystic ovary syndrome?

1 reference

12 December 2020

10.1007/S11892-007-0012-8

Identifiers

DOI

1 reference

15 August 2017

1 reference